Biomarkers in individualized management of chimeric antigen receptor T cell therapy | Biomarker Research | Full Text

Biomarkers in individualized management of chimeric antigen receptor T cell therapy | Biomarker Research | Full Text

Biomarkers in individualized management of chimeric antigen receptor T cell therapy

The development of chimeric antigen receptor (CAR) T cell immunotherapy has achieved promising results, both in clinical studies and in commercial products for patients with hematologic malignancies. Despite h...

Authors:Mengyi Du, Parameswaran Hari, Yu Hu and Heng Mei

Citation:Biomarker Research 2020 8:13

Content type:Review

Published on: 11 May 2020

• ViewFull Text
 
• ViewPDF